Skip to main content

Table 1 Demographic and clinical features

From: Identification of the molecular mechanism and diagnostic biomarkers in the thoracic ossification of the ligamentum flavum using metabolomics and transcriptomics

Patient No.

Gender

Age

Diagnosis

T1

M

35

T11-T12

T2

M

36

T7-10

T3

M

38

T2-T7

T4

M

40

T3-T5,T10-T11

T5

M

43

T9-L1

T6

M

47

T7-T11

T7

F

50

T9-T11

T8

M

50

T5-T7

T9

M

52

T4-T9

T10

F

52

T9-T11

T11

F

53

T3-T10

T12

F

54

T9-T11

T13

F

58

T2-T3

T14

F

58

T9-L1

T15

F

59

T5-L1

T16

M

59

T8-L5

T17

F

59

T1-T2

T18

F

60

T4-T5

T19

M

60

T2-T3

T20

M

61

T1-T3,T9-T12

T21

F

62

C4-T4

T22

M

65

T3-T4

T23

F

65

T3-T5

T24

F

65

T10-L1

T25

F

66

T9-T11

C1

M

59

ā€“

C2

M

35

ā€“

C3

M

40

ā€“

C4

M

50

ā€“

C5

M

59

ā€“

C6

M

37

ā€“

C7

F

50

ā€“

C8

F

50

ā€“

C9

F

41

ā€“

C10

F

60

ā€“

C11

M

62

ā€“

C12

F

62

ā€“

C13

M

45

ā€“

C14

M

63

ā€“

C15

F

65

ā€“

C16

F

63

ā€“

C17

F

37

ā€“

C18

F

58

ā€“

C19

M

64

ā€“

C20

M

59

ā€“

C21

F

51

ā€“

C22

M

55

ā€“

C23

F

61

ā€“

  1. T thoracic ossification of ligamentum flavum, C control